aspirin low dose

Generic: aspirin

Labeler: marc glassman, inc.
NDC Directory HUMAN OTC DRUG OTC MONOGRAPH DRUG Inactive Finished

Drug Facts

Product Profile

Brand Name aspirin low dose
Generic Name aspirin
Labeler marc glassman, inc.
Dosage Form TABLET, DELAYED RELEASE
Routes
ORAL
Active Ingredients

aspirin 81 mg/1

Manufacturer
Marc Glassman, Inc.

Identifiers & Regulatory

Product NDC 68998-146
Product ID 68998-146_27d89e9f-7a2e-1bb8-e063-6394a90a4b4e
Product Type HUMAN OTC DRUG
Marketing Category OTC MONOGRAPH DRUG
Application Number M013
Listing Expiration 2026-12-31
Marketing Start 2010-06-01

Pharmacologic Class

Established (EPC)
nonsteroidal anti-inflammatory drug [epc] platelet aggregation inhibitor [epc]
Mechanism of Action
cyclooxygenase inhibitors [moa]
Chemical Structure
anti-inflammatory agents, non-steroidal [cs]
Physiologic Effect
decreased prostaglandin production [pe] decreased platelet aggregation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 68998146
Hyphenated Format 68998-146

Supplemental Identifiers

RxCUI
308416
UPC
0094442601451
UNII
R16CO5Y76E
NUI
N0000000160 N0000008836 M0001335 N0000175722 N0000175578 N0000008832

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name aspirin low dose (source: ndc)
Generic Name aspirin (source: ndc)
Application Number M013 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 81 mg/1
source: ndc
Packaging
  • 1 BOTTLE, PLASTIC in 1 CARTON (68998-146-01) / 180 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC
source: ndc

Packages (1)

68998-146-01 1 BOTTLE, PLASTIC in 1 CARTON (68998-146-01) / 180 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC

Ingredients (1)

aspirin (81 mg/1)

Linked Drug Pages (1)

ASPIRIN Low Dose ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "27d89e9f-7a2e-1bb8-e063-6394a90a4b4e", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832"], "upc": ["0094442601451"], "unii": ["R16CO5Y76E"], "rxcui": ["308416"], "spl_set_id": ["3d519af3-9398-4439-8253-1e5d4612b8e3"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Marc Glassman, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PLASTIC in 1 CARTON (68998-146-01)  / 180 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC", "package_ndc": "68998-146-01", "marketing_start_date": "20100601"}], "brand_name": "ASPIRIN Low Dose", "product_id": "68998-146_27d89e9f-7a2e-1bb8-e063-6394a90a4b4e", "dosage_form": "TABLET, DELAYED RELEASE", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "product_ndc": "68998-146", "generic_name": "ASPIRIN", "labeler_name": "Marc Glassman, Inc.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "ASPIRIN", "brand_name_suffix": "Low Dose", "active_ingredients": [{"name": "ASPIRIN", "strength": "81 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20100601", "listing_expiration_date": "20261231"}